David Aharony

2.5k total citations
63 papers, 1.8k citations indexed

About

David Aharony is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David Aharony has authored 63 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 27 papers in Physiology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in David Aharony's work include Asthma and respiratory diseases (22 papers), Receptor Mechanisms and Signaling (17 papers) and Neuropeptides and Animal Physiology (15 papers). David Aharony is often cited by papers focused on Asthma and respiratory diseases (22 papers), Receptor Mechanisms and Signaling (17 papers) and Neuropeptides and Animal Physiology (15 papers). David Aharony collaborates with scholars based in United States, United Kingdom and Germany. David Aharony's co-authors include J. Bryan Smith, Robert D. Krell, Ross L. Stein, Allan M. Lefer, M.J. Silver, Edward F. Smith, David W. Snyder, Edward J. Kusner, Ronald L. Magolda and K. C. Nicolaou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

David Aharony

62 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Aharony United States 26 691 675 419 307 239 63 1.8k
Danielle Denis Canada 24 451 0.7× 597 0.9× 825 2.0× 478 1.6× 282 1.2× 37 2.0k
Dale E. Mais United States 32 625 0.9× 1.9k 2.9× 886 2.1× 554 1.8× 335 1.4× 107 3.9k
Shinji Terao Japan 21 342 0.5× 461 0.7× 328 0.8× 324 1.1× 146 0.6× 45 1.5k
Chi‐Chung Chan Canada 25 377 0.5× 1.0k 1.5× 1.2k 3.0× 709 2.3× 296 1.2× 41 2.7k
Tsumoru Miyamoto Japan 16 297 0.4× 489 0.7× 670 1.6× 183 0.6× 406 1.7× 22 1.7k
C S Ramesha United States 17 221 0.3× 636 0.9× 728 1.7× 302 1.0× 343 1.4× 27 1.8k
Werner Neidhart Switzerland 16 887 1.3× 943 1.4× 179 0.4× 274 0.9× 105 0.4× 30 2.2k
Giichi Goto Japan 19 733 1.1× 543 0.8× 395 0.9× 611 2.0× 195 0.8× 59 2.0k
William J. Chiou United States 23 736 1.1× 1.2k 1.8× 81 0.2× 197 0.6× 108 0.5× 57 2.2k
Ann F. Welton United States 25 451 0.7× 885 1.3× 180 0.4× 169 0.6× 133 0.6× 64 1.9k

Countries citing papers authored by David Aharony

Since Specialization
Citations

This map shows the geographic impact of David Aharony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Aharony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Aharony more than expected).

Fields of papers citing papers by David Aharony

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Aharony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Aharony. The network helps show where David Aharony may publish in the future.

Co-authorship network of co-authors of David Aharony

This figure shows the co-authorship network connecting the top 25 collaborators of David Aharony. A scholar is included among the top collaborators of David Aharony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Aharony. David Aharony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ohnmacht, Cyrus J., Jeffrey S. Albert, Peter R Bernstein, et al.. (2004). Naphtho[2,1-b][1,5] and [1,2-f][1,4]oxazocines as selective NK1 antagonists. Bioorganic & Medicinal Chemistry. 12(10). 2653–2669. 17 indexed citations
3.
Scott, Clay W., Deidre Wilkins, Robert T. Jacobs, et al.. (2003). Novel Small Molecule Inhibitors of Caspase-3 Block Cellular and Biochemical Features of Apoptosis. Journal of Pharmacology and Experimental Therapeutics. 304(1). 433–440. 48 indexed citations
4.
Bernstein, Peter R, David Aharony, Jeffrey S. Albert, et al.. (2001). Discovery of novel, orally active dual NK1/NK2 antagonists. Bioorganic & Medicinal Chemistry Letters. 11(20). 2769–2773. 29 indexed citations
5.
Veale, Chris A., David Aharony, Debra L. Banville, et al.. (2000). The discovery of non-basic atrial natriuretic peptide clearance receptor antagonists. part 1. Bioorganic & Medicinal Chemistry Letters. 10(17). 1949–1952. 28 indexed citations
6.
Aharony, David. (1998). Pharmacology of Leukotriene Receptor Antagonists. American Journal of Respiratory and Critical Care Medicine. 157(6). S214–S219. 61 indexed citations
7.
Jacobs, Robert T., et al.. (1998). 4-Alkylpiperidines related to SR-48968: Potent antagonists of the neurokinin-2 (NK2) receptor. Bioorganic & Medicinal Chemistry Letters. 8(14). 1935–1940. 6 indexed citations
8.
Aharony, David, Carl K. Buckner, James L. Ellis, et al.. (1995). Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity.. Journal of Pharmacology and Experimental Therapeutics. 274(3). 1216–1221. 6 indexed citations
9.
10.
11.
Brown, Frederick J., et al.. (1992). 1,3,6-Trisubstituted indoles as peptidoleukotriene antagonists: benefits of a second, polar, pyrrole substituent. Journal of Medicinal Chemistry. 35(13). 2419–2439. 13 indexed citations
12.
13.
Aharony, David, et al.. (1991). Binding of the novel ligand [4,5-3H-Leu10]substance P to high-affinity NK-1 receptors on guinea pig lung membranes: modulation by GTP analogs and sulfhydryl modifying agents.. Journal of Pharmacology and Experimental Therapeutics. 259(1). 146–155. 12 indexed citations
14.
Aharony, David & Robert D. Krell. (1991). Pharmacology of Peptide Leukotriene Receptor Antagonists. Annals of the New York Academy of Sciences. 629(1). 125–132. 5 indexed citations
15.
Aharony, David, et al.. (1991). Leukotriene D4 increases both the force of contraction and polyphosphoinositide formation in guinea-pig papillary muscle. European Journal of Pharmacology. 204(2). 223–226. 3 indexed citations
16.
Aharony, David, et al.. (1990). Further characterization of leukotriene d 4 ltd 4 receptors in the guinea pig left atria gpla. The FASEB Journal. 4(4). 1126. 2 indexed citations
17.
Krell, Robert D., David Aharony, Carl K. Buckner, et al.. (1990). The Preclinical Pharmacology of ICI 204,219: A Peptide Leukotriene Antagonist. American Review of Respiratory Disease. 141(4_pt_1). 978–987. 132 indexed citations
18.
Krell, Robert D., Edward J. Kusner, David Aharony, & Ralph E. Giles. (1989). Biochemical and pharmacological characterization of ICI 198,615: a peptide leukotriene receptor antagonist. European Journal of Pharmacology. 159(1). 73–81. 22 indexed citations
19.
Kusner, Edward J., et al.. (1989). Inhibition by REV-5901 of leukotriene release from guinea-pig and human lung tissue in vitro. Biochemical Pharmacology. 38(23). 4183–4189. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danielle Denis Breakdown of academic impact, for papers by Dale E. Mais Breakdown of academic impact, for papers by Shinji Terao Breakdown of academic impact, for papers by Chi‐Chung Chan Breakdown of academic impact, for papers by Tsumoru Miyamoto Breakdown of academic impact, for papers by C S Ramesha Breakdown of academic impact, for papers by Werner Neidhart Breakdown of academic impact, for papers by Giichi Goto Breakdown of academic impact, for papers by William J. Chiou Breakdown of academic impact, for papers by Ann F. Welton
Rankless by CCL
2026